Lepu Biopharma Temettü
Temettü kriter kontrolleri 0/6
Lepu Biopharma does not have a record of paying a dividend.
Anahtar bilgiler
n/a
Temettü verimi
-4.5%
Geri Alım Getirisi
| Toplam Hissedar Getirisi | -4.5% |
| Gelecekteki Temettü Verimi | 0% |
| Temettü Büyümesi | n/a |
| Bir sonraki temettü ödeme tarihi | n/a |
| Eski temettü tarihi | n/a |
| Hisse başına temettü | n/a |
| Ödeme oranı | n/a |
Son temettü güncellemeleri
Güncelleme yok
Recent updates
Lepu Biopharma (HKG:2157) Is Making Moderate Use Of Debt
Aug 23
The Price Is Right For Lepu Biopharma Co., Ltd. (HKG:2157) Even After Diving 27%
Jul 18Lepu Biopharma Co., Ltd. (HKG:2157) Stocks Pounded By 27% But Not Lagging Industry On Growth Or Pricing
Jun 03Revenues Not Telling The Story For Lepu Biopharma Co., Ltd. (HKG:2157) After Shares Rise 26%
Apr 15Ödemelerde İstikrar ve Büyüme
Temettü verilerini getirme
İstikrarlı Temettü: Insufficient data to determine if 2157's dividends per share have been stable in the past.
Büyüyen Temettü: Insufficient data to determine if 2157's dividend payments have been increasing.
Piyasaya Karşı Temettü Getirisi
| Lepu Biopharma Piyasaya Karşı Temettü Getirisi |
|---|
| Segment | Temettü Verimi |
|---|---|
| Şirket (2157) | n/a |
| Pazarın Alt %25'i (HK) | 3.2% |
| Pazarın En İyi %25'i (HK) | 7.9% |
| Sektör Ortalaması (Biotechs) | 1.1% |
| Analist tahmini (2157) (3 yıla kadar) | 0% |
Önemli Temettü: Unable to evaluate 2157's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
Yüksek Temettü: Unable to evaluate 2157's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Hissedarlara Ödenen Kazanç
Kazanç Kapsamı: Insufficient data to calculate 2157's payout ratio to determine if its dividend payments are covered by earnings.
Hissedarlara Nakit Ödeme
Nakit Akışı Kapsamı: Unable to calculate sustainability of dividends as 2157 has not reported any payouts.